ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

122
Analysis
Health Care • Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
•19 May 2024 07:05

Yichang HEC (1558 HK): Absorption Via Speculative Scrip. Avoid

Maybe this gets up. Maybe this is worth HK$19.30/share.  Too many maybes. If in, I'd vote this transaction down. If not in, I'd be looking elsewhere.

Logo
598 Views
Share
bullish•Japan Post Holdings
•19 May 2024 07:00

Last Week in Event SPACE: Japan Post, Great Eastern, Malaysia Airports, L'Occitane

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
718 Views
Share
bullish•ESR Group
•18 May 2024 15:00

(Mostly) Asia-Pac M&A: ESR Group, I'Rom Group, S Line, Huafa Property Services, Kansai Super Market

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
726 Views
Share
•16 May 2024 08:55

HEC CJ Pharma (1558.HK)'s Merger Deal with Sunshine Lake Pharma - Almost No Investment Value

​Sunshine Lake Pharma plans to privatize and merge with CJ Pharma.However, with an outdated pipeline, the new entity's valuation performance will...

Logo
614 Views
Share
•13 May 2024 04:35

Merger Arb Mondays (13 May) - GA Pack, HEC Pharma, L'Occitane, Alps Logistics, Great Eastern

This week, the highest gross spreads are HEC Pharma (58.1%), Alps Logistics (14.3%), Hollysys (12.9%), Ansarada (8.7%), Southern Cross (8.7%), QV...

Logo
509 Views
Share
x